Trastuzumab Deruxtecan in Patients with HER2-Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results from the Randomized, Phase II DESTINY-Lung02 Trial
- Koichi Goto
- , Yasushi Goto
- , Toshio Kubo
- , Kiichiro Ninomiya
- , Sang We Kim
- , David Planchard
- , Myung Ju Ahn
- , Egbert F. Smit
- , Adrianus Johannes De Langen
- , Maurice Pérol
- , Elvire Pons-Tostivint
- , Silvia Novello
- , Hidetoshi Hayashi
- , Junichi Shimizu
- , Dong Wan Kim
- , Chih Hsi Kuo
- , James Chih Hsin Yang
- , Kaline Pereira
- , Fu Chih Cheng
- , Ayumi Taguchi
- National Cancer Center Japan
- Okayama University
- University of Ulsan
- Gustave Roussy
- Leiden University
- Netherlands Cancer Institute
- Centre Léon Bérard
- Nantes University
- Azienda Ospedaliera S. Luigi Gonzaga
- Kindai University
- Aichi Cancer Center Hospital and Research Institute
- Seoul National University
- Chang Gung University
- National Taiwan University
- Daiichi Sankyo Company, Limited
- Dana-Farber Cancer Institute
Research output: Contribution to journal › Article › peer-review
295
Link opens in a new tab
Scopus
citations